Markers of Antioxidant Defense in Patients with Type 2 Diabetes

Table 2

Comparison of antioxidant defense markers in patients with type 2 diabetes and controls.

Parameter	Type 2 diabetes	Control group
FRAP [mmol/L]	0.97 ± 0.21	0.84 ± 0.16	<0.001
GPxplasma [U/L]	235.7 (93.2–359.9)	644.5 (466.0–798.8)	<0.001
GPxhemolysate [U/gHb]	43.8 ± 21.5	55.4 ± 25.9	0.002
GRplasma [U/L]	74.5 ± 21.3	43.7 ± 13.5	<0.001
GRhemolysate [U/gHb]	33.0 (26.9–38.5)	22.62 (16.2–29.1)	<0.001
GSH [μmol/L]	0.87 (0.46–2.23)	0.92 (0.56–1.20)	0.117
Uric acid [mol/L]	364.3 ± 117.9	293.5 ± 85.7	<0.001
GGT [U/L]	23.5 (11.5–37.5)	10.5 (7.0–17.0)	<0.001
CRP [mg/dL]	1.95 (0.85–5.72)	0.87 (0.46–2.23)	<0.001

Data are expressed as mean ± SD and median and interquartile range.